Adams Respiratory Therapeutics, Inc.

Pharmaceutical firm sets price for public offering

Published in Pharma Investments, Ventures and Law Weekly, August 28th, 2005

Adams Respiratory Therapeutics, Inc., (ARXT) announced the pricing of its initial public offering of 7,950,000 shares of its common stock at a price of $17.00 per share. Of the 7,950,000 shares being sold in the offering, 5,697,000 are being sold by Adams and 2,253,000 are being sold by certain selling stockholders.

In addition, Adams has granted to the underwriters a 30-day over-allotment option to purchase up to an additional 1,192,000 shares. The Adams common stock is expected to begin trading on the Nasdaq National Market on July 21, 2005, under the symbol "ARXT."

The proceeds to Adams from the offering are expected to be approximately $87.7...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2005-08-28)

More Articles from Pharma Investments, Ventures and Law Weekly

454 Life Sciences
Life science instrumentation maker gets $11.5M in milestones
Abbott Laboratories
Pharma firm reaches agreement with Brazilian government for AIDS drug
Abgenix, Inc.
Pharmaceutical firm reports loss of $0.94 per share
Able Laboratories, Inc.
Pharmaceutical firm files for Chapter 11 reorganization
Adams Respiratory Therapeutics, Inc.
Pharmaceutical firm announces underwriter exercises option
Advanced Magnetics, Inc.
Nanotechnology company included in new Russell Microcap Index
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry